The $156 Multi Lilly Hearts Disney Ballad Sweatshirt is becoming a vacation must-have despite being slightly smaller than the original version that loyal customers love.

Apple is reportedly working on a new Magic Mouse. Below, we recap what to expect. The two key rumors for the Magic Mouse 3 so far include a relocated charging port, along with a more ergonomic design.

An expert panel of the EU drug regulator, the European Medicines Agency (EMA), on Friday declined to endorse Kisunla (donanemab), Eli Lilly’s (NYSE:LLY) candidate for early Alzheimer’s disease ...

33,062 people played the daily Crossword recently. Can you solve it faster than others?33,062 people played the daily Crossword recently. Can you solve it faster than others?

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. This image provided by Eli Lilly shows the company ...

Apparel company Lululemon on Thursday became the latest retailer to warn that slumping consumer confidence will hurt sales, while the parent company of Tommy Bahama, Lilly Pulitzer, and Johnny Was ...

Kiwi designer Sera Lilly found fast-fashion website Shein had been taking her images and designs without her knowledge. Composite / Kennedy Anderson, Screenshot Shein - the world’s largest ...

You can reach Allison on Signal at AllisonDeAngelis.01. European Medicines Agency advisers said Friday that Eli Lilly’s Alzheimer’s disease treatment should not be approved, once again ...

EU rejection based on risk of serious brain swelling Lilly seeks re-examination of EU decision on Kisunla CHMP previously rejected Leqembi before recommending approval March 28 (Reuters ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The EU’s medicines regulator has declined to approve Eli Lilly’s new Alzheimer’s drug, deciding the ...

Eli Lilly’s Alzheimer’s drug Kisunla has received a negative opinion from the European Union’s drug evaluation board. Meanwhile, competitors Biogen and Eisai are still fighting for market access for ...